Not applicableStudy completedNCT04236102What this trial is testingKEBI-Cyto Study - Use of the Biocartis IdyllaWho this might be right forPancreatic AdenocarcinomaLung Cancer Royal Cornwall Hospitals Trust 55
Early research (Phase 1)Ended earlyNCT05831995What this trial is testingSafety and Effectiveness of ABM-168 in Adults with Advanced Solid Tumors.Who this might be right forAdvanced Solid TumorRAS MutationRAF Mutation+1 more ABM Therapeutics Corporation 12
Early research (Phase 1)Ended earlyNCT04249843What this trial is testingStudy of Safety, Pharmacokinetics, and Antitumor Activity of BGB-3245 in Participants With Advanced or Refractory TumorsWho this might be right forSolid TumorB-Raf Mutation-Related Tumors MapKure, LLC 109
Early research (Phase 1)Looking for participantsNCT06299839What this trial is testingPAS-004 in Patients With Advanced Solid TumorsWho this might be right forRAS MutationNF1 MutationRAF Mutation+1 more Pasithea Therapeutics Corp. 48
Large-scale testing (Phase 3)Looking for participantsNCT07440290What this trial is testingDETERMINE Trial Treatment Arm 07: Dabrafenib in Combination With Trametinib in Adult, Paediatric and Teenage/Young Adult Patients With BRAF V600 Mutation-Positive Cancers.Who this might be right forHaematological MalignancyMalignant NeoplasmLymphoproliferative Disorders+17 more Cancer Research UK 30
Early research (Phase 1)Study completedNCT01337765What this trial is testingSafety, Pharmacokinetics and Pharmacodynamics of BEZ235 Plus MEK162 in Selected Advanced Solid Tumor PatientsWho this might be right forUnspecified Adult Solid Tumor, Protocol SpecificSolid Tumor Pfizer 29
Testing effectiveness (Phase 2)Active Not RecruitingNCT04625270What this trial is testingAvutometinib (VS-6766) v. Avutometinib (VS-6766) + Defactinib in Recurrent Low-Grade Serous Ovarian Cancer With and Without a KRAS MutationWho this might be right forLow Grade Ovarian Serous AdenocarcinomaOvarian Cancer Verastem, Inc. 225
Early research (Phase 1)Active Not RecruitingNCT06104488What this trial is testingAvutometinib for People With Solid Tumor CancersWho this might be right forRefractory CancerCNS TumorsCNS Tumor, Adult+12 more Memorial Sloan Kettering Cancer Center 3
Testing effectiveness (Phase 2)Study completedNCT02768207What this trial is testingDetect V-Raf Murine Sarcoma Viral Oncogene Homolog B1 (BRAF) V600 Mutation on Cell-Free Deoxyribonucleic Acid (cfDNA) From Plasma in Participants With Advanced MelanomaWho this might be right forMetastatic Melanoma Hoffmann-La Roche 40
Early research (Phase 1)Ended earlyNCT07121829What this trial is testingTovorafenib (DAY101) or in Combination With Pimasertib for Participants With Melanoma and Other Solid TumorsWho this might be right forMelanomaSolid TumorPilocytic Astrocytoma+7 more Day One Biopharmaceuticals, Inc. 44
Early research (Phase 1)Ended earlyNCT04800822What this trial is testingPF-07284892 in Participants With Advanced Solid TumorsWho this might be right forSolid Tumor Pfizer 53
Early research (Phase 1)Study completedNCT01436656What this trial is testingA Phase I Study of Oral LGX818 in Adult Patients With Advanced or Metastatic BRAF Mutant MelanomaWho this might be right forMelanoma and Metastatic Colorectal Cancer Pfizer 107
Testing effectiveness (Phase 2)Ended earlyNCT04585815What this trial is testingStudy of Immunotherapy (Sasanlimab) in Combination With Targeted Therapies in People With Advanced Non-small Cell Lung Cancer (NSCLC) (Landscape 1011 Study)Who this might be right forCarcinoma, Non-Small-Cell Lung Pfizer 34
Not applicableLooking for participantsNCT05868629What this trial is testingClinical Study To Further Evaluate The Efficacy Of Dabrafenib Plus Trametinib In Patients With Rare BRAF V600E Mutation-Positive Unresectable or Metastatic Solid TumorsWho this might be right forRare Unresectable or Metastatic BRAF V600E Mutation-positive Solid Tumors Novartis Pharmaceuticals 40
Testing effectiveness (Phase 2)Study completedNCT01116271What this trial is testingStudy of Selumetinib (AZD6244)(ARRY-142886) in Combination With Irinotecan in Previously Treated Patients With ColorecWho this might be right forColorectal Cancer AstraZeneca 32
Testing effectiveness (Phase 2)Study completedNCT01086267What this trial is testingSafety and Efficacy Study of BMS-908662 Alone or in Combination With Cetuximab in Subjects With K-RAS or B-RAF Mutation Positive Advanced or Metastatic Colorectal CancerWho this might be right forColorectal Cancer Bristol-Myers Squibb 17
Not applicableUnknownNCT06081270What this trial is testingProspective Study on Resistance-associated Mutations in Metastatic Lung CancerWho this might be right forLung Cancer University of Milano Bicocca 20
Testing effectiveness (Phase 2)Study completedNCT01781026What this trial is testingPhase 2 Study of Neoadjuvant Vemurafenib in Melanoma Patients With Untreated Brain MetastasesWho this might be right forMelanoma Yale University 2
Testing effectiveness (Phase 2)Ended earlyNCT01514864What this trial is testingTrial of Dasatinib in Patients With Advanced Cancers Harboring DDR2 Mutation or Inactivating B-RAF MutationWho this might be right forCarcinoma, Non-small Cell Lung Bristol-Myers Squibb 19
Testing effectiveness (Phase 2)Study completedNCT05068752What this trial is testingPhase II Trial of Vemurafenib and Sorafenib in Pancreatic CancerWho this might be right forPancreas Cancer HonorHealth Research Institute 10